Federal funding of $2B to support biotechnology and biomanufacturing

By The Science Advisory Board staff writers

September 14, 2022 -- The White House announced on Wednesday federal funding of more than $2 billion to advance President Joe Biden's executive order intended to enable the U.S. to harness the full potential of biotechnology and biomanufacturing.

Biden's executive order, signed on Monday, launched a National Biotechnology and Biomanufacturing Initiative aimed at reducing U.S. reliance on foreign materials and bioproduction, while directing federal agencies to identify priority R&D needs to translate bioscience and biotech discoveries into medical breakthroughs and to strengthen domestic supply chains.

Of the more than $2 billion in funding for the initiative, the Department of Defense (DoD) will invest $1 billion in U.S. manufacturing infrastructure over five years to "catalyze the establishment of the domestic bioindustrial manufacturing base" and "provide incentives for private- and public-sector partners to expand manufacturing capacity for products important to both commercial and defense supply chains, such as critical chemicals," states a White House fact sheet.

To strengthen supply chains, the Department of Health and Human Services will invest $40 million to "expand the role of biomanufacturing for active pharmaceutical ingredients, antibiotics, and the key starting materials needed to produce essential medications and respond to pandemics," according to the announcement.

The Department of Commerce (DOC) plans to invest an additional $14 million next year at the National Institute of Standards and Technology for biotechnology research programs to develop measurement technologies, standards, and data for the U.S. bioeconomy.

"This support will catalyze development of capabilities for engineering biology, advance biomanufacturing processes and technologies, and help utilize artificial intelligence to analyze biological data," states the White House fact sheet.

BioFabUSA and BioMADE, part of the Manufacturing USA network which was launched by the DoD, and the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), launched by the DOC, will expand their industry partnerships to enable commercialization across regenerative medicine, industrial biomanufacturing, and biopharmaceuticals.

"NIIMBL will launch a biomanufacturing initiative that will engage the institute's 200 partners across industry, academic, nonprofit, and federal agencies to mature biomanufacturing technology needed to improve patient access to gene therapies," according to the announcement.

The White House also said that the National Institutes of Health's Accelerating Medicines Partnership Bespoke Gene Therapy Consortium will support up to six new clinical trials, each focused on a different rare disease, to streamline manufacturing and regulatory frameworks.

In a written statement, the Alliance for Regenerative Medicine (ARM) said it welcomed the Biden administration’s efforts to accelerate patient access to gene therapies as part of its National Biotechnology and Biomanufacturing Initiative.

“The Administration recognizes that gene therapy is vital for the U.S. bioeconomy and that addressing manufacturing and regulatory frameworks is crucial to ensuring patient access. ARM and NIIMBL -- a key stakeholder in the initiative -- partnered on Project A-Gene, a multistakeholder collaboration to bring best practices to gene therapy manufacturing through the application of quality-by-design principles,” said Stephen Majors, ARM’s senior director of public affairs.

Majors noted that ARM is also a partner in the Bespoke Gene Therapy Consortium, which seeks to develop gene therapies for ultra-rare diseases and to streamline manufacturing and regulatory frameworks for future gene therapies and patients.

The Biden administration made the funding announcement on Wednesday to coincide with a summit the White House is hosting on biotech and biomanufacturing.

Biden executive order launches National Biotechnology and Biomanufacturing Initiative
President Joe Biden signed an executive order today that is intended to allow the U.S. to harness the potential of biotechnology and biomanufacturing,...
ElevateBio, University of Pittsburgh awarded $100M grant to create biomanufacturing center
ElevateBio and the University of Pittsburgh have been awarded a $100 million grant from the Richard King Mellon Foundation to create the Pitt BioForge...
NSF awards $6M to develop purification membranes for large-scale manufacturing of viral vectors
The National Science Foundation (NSF) has awarded a $6 million grant to researchers at the University of Arkansas and two partner institutions to develop...

Copyright © 2022 scienceboard.net


Conferences
BioProcess International (BPI) Conference
September 27-30
Boston, Massachusetts United States
Laboratory Products Association Annual Meeting
October 1-4
Scottsdale, Arizona United States
Cell & Gene Meeting on the Mesa
October 11-13
Carlsbad, California United States
IDWeek 2022
October 19-23
District of Columbia United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter